跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
癌症生物學與藥物研發博士學位學程
臺北醫學大學
醫學科技學院
電話
+886-2-27361661#7605
電子郵件
[email protected]
網站
http://crdd.tmu.edu.tw
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(21)
專案
(295)
研究成果
(2397)
資料集
(88)
指紋
查看啟用 癌症生物學與藥物研發博士學位學程 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
61%
Colorectal Cancer
38%
Breast Cancer
27%
Prostate Cancer
27%
IC50
26%
Liver Cell Carcinoma
25%
Mouse
24%
Disease
20%
Protein P53
18%
Anticarcinogen
17%
Tumor Growth
17%
Glioblastoma
16%
Histone Deacetylase Inhibitor
15%
Tubulin
15%
Cancer Growth
14%
Chemotherapy
14%
Lung Cancer
14%
Epidermal Growth Factor Receptor
14%
Carcinogenesis
13%
Biological Marker
13%
Cytotoxicity
13%
Integrin
12%
Non Small Cell Lung Cancer
12%
Phosphotransferase
12%
Histone Deacetylase
12%
Colon Cancer
12%
Western Blot
11%
Thyroid Hormone
11%
Reactive Oxygen Metabolite
11%
Drug Resistance
11%
Inflammation
10%
Metastasis
10%
Histone Deacetylase 6
10%
microRNA
9%
Antitumor Activity
9%
Cohort Study
9%
Nitric Oxide
9%
Caspase 3
9%
Pancreas Cancer
8%
Receptor
8%
Nanoparticle
8%
Mitogen Activated Protein Kinase
8%
Cell Viability
8%
Cytokine
8%
Androgen Receptor
8%
Cisplatin
7%
Overall Survival
7%
Antioxidant
7%
Antiproliferative Activity
7%
Mitogen Activated Protein Kinase 3
7%
Lung Adenocarcinoma
7%
Small Interfering RNA
7%
Resveratrol
7%
Tumor Necrosis Factor
7%
Pharmacokinetics
7%
Nuclear Factor
7%
Bladder Cancer
7%
Colorectal Carcinoma
7%
Hydroxamic Acid
7%
Combination Therapy
7%
Nicotinic Receptor
6%
Ribonucleotide Reductase
6%
Vorinostat
6%
Caspase
6%
Glutathione
6%
Brain Ischemia
6%
Lipopolysaccharide
6%
Ovary Cancer
6%
Well Water
5%
Mammalian Target of Rapamycin
5%
Virtual Screening
5%
Diabetes Mellitus
5%
Hypoxia
5%
Cigarette Smoking
5%
Mouth Cancer
5%
Injury
5%
Castration Resistant Prostate Cancer
5%
Mouse Model
5%
Cyclooxygenase 2
5%
Triple Negative Breast Cancer
5%
Anti-Inflammatory Drug
5%
Stomach Cancer
5%
Solid Malignant Neoplasm
5%
Alternative Complement Pathway C3 C5 Convertase
5%
Clinical Trial
5%
Cytochrome P450
5%
Androgen
5%
STAT3 Protein
5%
Chronic Kidney Failure
5%
DNA Topoisomerase
5%
Propofol
5%
Recurrent Disease
5%
Protein Tyrosine Kinase Inhibitor
5%
Flow Cytometry
5%
Hydrogen Peroxide
5%
Nude Mouse
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
80%
Gene Expression
19%
Signal Transduction
17%
Cell Proliferation
16%
Thyroid Hormone
15%
Autophagy
15%
MicroRNA
15%
Anticancer
15%
P53
14%
Carcinogenesis
14%
Integrin
13%
Tumor Progression
13%
Drug Resistance
13%
Upregulation
13%
Colon
12%
Phosphotransferase
12%
Kinase
12%
Epidermal Growth Factor Receptor
12%
Messenger RNA
11%
Cell Migration
11%
Mouse
11%
Mesenchymal-Epithelial Transition
11%
Catenin
10%
Cell Cycle
10%
IC50
10%
Eicosanoid Receptor
9%
down Regulation
9%
Small Molecule
8%
Overall Survival
8%
Angiogenesis
8%
Protein Expression
8%
Antineoplastic Activity
8%
Androgen Receptor
8%
Ribonucleotide Reductase
7%
Histone Deacetylase
7%
Estrogen Receptor
7%
Promoter Region
7%
Multigene Family
6%
Transcription
6%
Cytotoxicity
6%
Osteoblast
6%
Cell Growth
6%
Glucose-Regulated Protein
6%
Stem Cell
6%
Enzyme
6%
Metabolic Pathway
5%
Computer Model
5%
RNA
5%
Survival Rate
5%
Cell Invasion
5%
Genotyping
5%
Cell Death
5%
Western Blot
5%
Wart Virus
5%
Mitochondrion
5%
Medicine and Dentistry
Cancer Cell
34%
Neoplasm
34%
Malignant Neoplasm
30%
Breast Cancer
24%
Metastatic Carcinoma
21%
Colorectal Cancer
20%
In Vitro
18%
Programmed Cell Death
17%
Prostate Cancer
17%
Hepatocellular Carcinoma
15%
Carcinogenesis
12%
Signal Transduction
11%
Radiation Therapy
10%
Cancer
10%
Apoplexy
9%
Disease
9%
Gene Expression
9%
Upregulation
9%
Biological Marker
9%
Tumor Progression
9%
Cell Proliferation
8%
Cancer Growth
8%
Glioblastoma
8%
Protein P53
8%
Cohort Analysis
8%
Nasopharynx Carcinoma
8%
Tumor Cell
7%
Cancer Therapy
7%
Overall Survival
7%
Brain Ischemia
6%
Lung Cancer
6%
Non Small Cell Lung Cancer
6%
microRNA
6%
Epidermal Growth Factor Receptor
6%
Rectum Cancer
6%
Autophagy
6%
Wart Virus
6%
Carcinoma Cell
6%
Meta-Analysis
6%
Xenograft
6%
Thyroid Hormone
6%
Colon Cancer
5%
Androgen Receptor
5%
Integrin
5%
Cell Cycle
5%
Histone Deacetylase
5%
down Regulation
5%
Drug Resistance
5%
Protein Expression
5%
Antineoplastic Activity
5%
Bone Metastasis
5%
Diabetes
5%
Infection
5%
Cytotoxicity
5%
Systematic Review
5%
Odds Ratio
5%
Randomized Controlled Trial
5%
Cell Migration
5%